SANDOZ AMBRISENTAN
SANDOZ AMBRISENTAN
Discontinued
DIN Number
02525313
Drug Class
Human
Market Date
N/A
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02525313
AIG Number0152452002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02KX02 AMBRISENTAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:48.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AMBRISENTANActive
Strength: 10 MG
Monograph: AMBRISENTAN